Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			Vaccines site
			Vaccines site
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


Vaccines & Immunizations


Section Navigation
			
			CDC Home








Building Confidence in COVID-19 Vaccines						Print
																Related Pages
										Vaccinate with confidence. CDC's strategy to reinforce confidence in COVID-19 vaccinesVaccinate with Confidence is the strategic framework of the Centers for Disease Control and Prevention (CDC) to strengthen vaccine confidence and prevent outbreaks of vaccine-preventable diseases in the United States.
**Strong confidence in COVID-19 vaccines within communities leads to more adults, adolescents, and children getting vaccinated****― which leads to fewer COVID-19 illnesses, hospitalizations, and deaths.**CDC COVID-19 Vaccine Confidence ResourcesWhat is Vaccine Confidence?CDC COVID-19 Vaccine Confidence Strategy12 Community-Based COVID-19 Vaccination StrategiesRapid Community Assessment GuideEngaging the Arts to Build COVID-19 Vaccine ConfidenceReaching People with Limited Access to COVID-19 VaccinesHow to Address COVID-19 Vaccine MisinformationHow to Tailor COVID-19 Information to Your Specific AudienceWays Health Departments Can Help Increase COVID-19 VaccinationsCOVID-19 State of Vaccine Confidence Insights ReportsCDC regularly creates reports about the status of COVID-19 vaccine confidence in the United States, emphasizing major themes that influence vaccine confidence and uptake. The reports include analyses of multiple quantitative and qualitative data sources, ranging from social listening and web metrics to immunization survey data and CDC-INFO inquiries.Recent ReportsThe following reports seek to identify emerging issues of misinformation, disinformation, and places where intervention efforts can positively increase vaccine confidence across the United States.
Special Report – Vaccine Hesitancy Among Pregnant People [22 pages]
Special Report – Respiratory Viruses: COVID-19, RSV and Flu [18 pages]
Special Report – RSV Vaccination in Older Adults | September 1, 2023 [20 pages]
Special Report – Vaccination in Rural America | September 25, 2023 [19 pages]
2023 Quarter 1 Report | August 28, 2023 [20 pages]
2022 Quarter 4 Report | July 7, 2023 [23 pages]Previous ReportsClick the bold text below to view previous reports.View Previous ReportsSpecial Report – Chicago Monkeypox Outbreak | June 30, 2023 [12 pages]
Special Report – Monkeypox Outbreak | May 22, 2023 [18 pages]
Special Report – Long-Term Care Settings | May 22, 2023 [13 pages]
2022 Quarter 3 Report | January 26, 2023 [24 pages]
Rapid Report – Updated (Bivalent) Booster Report | December 22, 2022 [17 pages]
2nd COVID-19 Vaccine Summary Report: 6 months through 5 years | December 16, 2022 [11 pages]
Routine Immunizations on Schedule for Everyone (RISE) SoVC Report | November 10, 2022 [15 pages]
Summary Report – Monkeypox Vaccine | October 14, 2022 [11 pages]
Report 28 | October 10, 2022 [11 pages]
Report 27 | August 10, 2022 [14 pages]
Report 26 | June 17, 2022 [12 pages]
Report 25 | May 12, 2022 [13 pages]
Report 24 | March 28, 2022 [11 pages]
Summary Report – COVID-19 Vaccines for Children | February 24, 2022 [3 pages]
Report 23 | February 24, 2022 [10 pages]
Report 22 | February 2, 2022 [9 pages]
Report 21 | January 26, 2021 [7 pages]
Report 20 | December 20, 2021 [5 pages]
Report 19 | December 14, 2021 [8 pages]
Rapid Report – SARS-CoV-2 Omicron Variant | December 10, 2021 [7 pages]
Rapid Report – Announcement of Pediatric COVID-19 Vaccines for Children ages 5-11 years old | November 15, 2021 [7 pages]
Report 18 | November 10, 2021 [7 pages]
Report 17 | October 26, 2021 [8 pages]
Report 16 | October 15, 2021 [8 pages]
Report 15 | September 27, 2021 [6 pages]
Rapid Report – Announcement of Booster Dose Program of mRNA COVID-19 Vaccines for U.S. Adults | August 26, 2021 [8 pages]
Report 14 | September 13, 2021 [8 pages]
Report 13 | September 2, 2021 [8 pages]
Report 12 | July 26, 2021 [9 pages]
Rapid Report – Cases of Myocarditis and Pericarditis following mRNA COVID-19 Vaccination | June 29, 2021 [8 pages]
Report 11 | July 7, 2021 [6 pages]
Report 10 | June 21, 2021 [7 pages]
Special Report – Pfizer-BioNTech COVID-19 Vaccine for Adolescents Aged 12 through 15 Years | June 14, 2021 [9 pages]
Report 9 | June 7, 2021 [8 pages, 2 MB]
Report 8 | May 24, 2021 [9 pages, 2 MB]
Report 7 | May 10, 2021 [10 pages, 2 MB]
Report 6 | April 28, 2021 [8 pages, 2 MB]
Rapid Report – Recommendation for J&J/Janssen vaccine pause | April 20, 2021 [8 pages, 385 KB]
Report 5 | April 12, 2021 [9 pages, 3 MB]
Report 4 | March 29, 2021 [8 pages, 2 MB]
Report 3 | March 15, 2021 [9 pages, 2 MB]
Report 2 | March 1, 2021 [7 pages, 2 MB]
Report 1 | February 12, 2021 [8 pages, 1 MB]*Disclaimer: The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC).*
**Interested in receiving the report? Sign up for our email list.Additional Resources for Building Vaccine Confidence in COVID-19 VaccinesTalking with Patients about COVID-19 Vaccination
Talking with Parents about COVID-19 Vaccination
Myths and Facts about COVID-19 Vaccines
Community Engagement PlaybookCOVID-19 Vaccine Confidence DataExplore trends in COVID-19 vaccine confidence in the U.S.
COVID-19 Data Tracker Weekly Review
COVIDVaxView InteractiveCOVID-19 Health Equity ResourcesCOVID-19 Vaccine Equity for Racial and Ethnic Minority Groups
A Guide for Community Partners: Increasing COVID-19 Vaccine Uptake Among Members of Racial and Ethnic Minority Communities
							
					
							Last Reviewed:  December 20, 2023						Source: 	National Center for Immunization and Respiratory Diseases
					Facebook
        Twitter
        LinkedIn
        Syndicate homeCOVID-19 Vaccination
Product Info by U.S. Vaccineplus icon
EUA
EUI
Interim Clinical Considerationsplus icon
Use of COVID-19 Vaccines in the U.S.
Use of COVID-19 Vaccines in the U.S.: Appendices
FAQs for the Interim Clinical Considerations
Myocarditis and Pericarditis Considerations
Clinical Care
Provider Requirements and Support
Vaccine Recipient Educationplus icon
Talking with Patients about COVID-19 Vaccination
How to Tailor COVID-19 Information to Your Audience
How to Address COVID-19 Vaccine Misinformation
Health Departments
Planning & Partnerships
6 Things to Know
Equity in Childhood COVID-19 Vaccination
COVID-19 Vaccine Data Systemsplus icon
Overviewplus icon
Vaccine IT Overview
Data Reporting Requirements
Vaccine Administration Management System (VAMS)plus icon
Getting Started in VAMS
General Public User
Resources for Jurisdictions, Clinics, and Organizations
VAMS Program Information
Vaccinate with Confidenceplus icon
What Is Vaccine Confidence?
Vaccine Confidence Strategies
Rapid Community Assessment Guide
COVID-19 Vaccine Confidence Data
12 COVID-19 Vaccination Strategies for Your Community
How to Engage the Arts to Build COVID-19 Vaccine Confidence
Strategies for Reaching People with Limited Access to COVID-19 Vaccines


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue